Factor VIII is a crucial blood-clotting protein, deficiencies or dysfunctions of which can lead to hemophilia A, a genetic disorder that impairs the body's ability to form blood clots. It is often administered as a therapeutic agent in individuals with hemophilia A to prevent excessive bleeding and manage the condition effectively.